Systematic review on urine albumin testing for early detection of diabetic complications.
about
Urinary Biomarkers in the Assessment of Early Diabetic NephropathyImprovements in the Management of Diabetic NephropathyAdolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT)Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: From risk association to risk predictionAnalysis of urinary proteomic patterns for diabetic nephropathy by ProteinChip.Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study.Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES studyQuality of diabetes care at outpatient clinic, sultan qaboos university hospitalFive-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES StudyThe synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP).HLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control studyPredictors for diabetic retinopathy in normoalbuminuric people with type 2 diabetes mellitusRenin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences.Need for quality improvement in renal systematic reviews.Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetesStudy of Adiponectin Level in Diabetic Adolescent Girls in Relation to Glycemic Control and Complication of DiabetesMicroalbuminuria screening in patients with hypertension: recommendations for clinical practice.Microalbuminuria measured by three different methods, blood pressure and cardiovascular risk factors in elderly Swedish males.TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathyDiabetic nephropathy: Is it time yet for routine kidney biopsy?Management of diabetes in patients with chronic kidney disease.Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and meta-analysis.Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries.Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review.Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics.Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.Precision Medicine Approaches to Diabetic Kidney Disease: Tissue as an Issue.The ZDSD rat: a novel model of diabetic nephropathy.Angiotensin-converting enzyme inhibition curbs tyrosine nitration of mitochondrial proteins in the renal cortex during the early stage of diabetes mellitus in rats.Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America.The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetes.Diabetic kidney disease.Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.Retinopathy in subjects with type 2 diabetes at a tertiary diabetes clinic in Durban, South Africa: Clinical, biochemical and genetic factors.
P2860
Q26740305-771BB073-5607-4767-AB3C-1BE244E21A07Q28080717-29DFB0F5-2198-471D-9537-A2EE9F02CBBCQ33519176-9FF3201F-BA7D-472E-A710-9981042227BFQ33603455-DE2B321B-8A85-4C1B-87E5-43EF54078FE8Q33764401-967AD0BF-9BD3-4FC2-B1D5-3AF0FD862C01Q33988764-820D8DB6-2056-462C-9B51-A1CE0B52EB05Q34008233-908B0421-EFA1-4632-8352-5D88295BDBE1Q34219439-51DEE6C2-70F4-4539-9B39-45D2AA1E3838Q34429278-D1511C87-6503-4F91-A2AE-5C0165E19BFFQ34453548-5F9D553D-7C8C-4444-8D7D-B65A7CC0D6E5Q34736194-2D1CFB23-538A-423B-BF5B-32643CEC53F8Q35022756-2D81A51F-82BE-4224-9B87-A225F58E2AFAQ35211205-04B36620-CB10-42D5-9E83-E9105037C44DQ35344925-A96814FD-2E0A-42CF-903E-73475253BF66Q35821305-355513F3-81A1-482C-A61C-CB841C265A3CQ35976961-5E33DB49-D2FF-4173-B525-B0D911732ACBQ36125538-BA09F5FB-3F58-4916-B1D0-A7BE68EB866AQ36329456-6AF24973-C3FE-4900-8C0B-C8B928FC5D10Q36736617-E4DD876A-121B-418D-8F1D-DD838EAA458FQ36842641-CFA8F081-F621-492F-9C09-BD8641B462EBQ36929445-3EC48AF9-D31B-4A26-A490-5606DFE507CFQ36986163-DEE192A6-4D54-4B50-A88E-85C79E6E346EQ37260097-297A55E7-BD65-46D8-9513-C7DF2FE785FCQ37292151-2E4443A8-F63B-4FAA-BBC2-EDB3791FE092Q37417746-09818596-FA49-4BF0-A5E1-50EF97A6CC60Q37505862-0934B987-770E-416C-A733-B72E41958B16Q37601897-840F7138-F7EA-46F2-B01B-386A2139808AQ37668647-EF2B0F9F-32B2-4AA8-87DC-05C29835A0A0Q37931336-6481294C-9EA7-4F1B-B078-A4A30F297E70Q39118882-BD23DCB3-DDEF-4328-8DAA-AF8D4A7B3390Q39165618-03DC61F4-0092-42D3-8C26-B7E457E14CDDQ39212398-CA894A81-1B21-4FD3-B80E-A5F0F550B907Q41965910-F375B541-7062-460A-B603-531E47E00423Q42104057-10493C16-9616-4523-8793-0E091329BA09Q42376848-24183277-3BC3-4284-82F2-809474A22852Q42998927-A6991CB8-B166-4BCD-9359-D3E601BF607FQ43721013-3677C9E5-B18C-46B0-A9D0-15B469845CA3Q44871811-5DE7C3A9-59E7-4D28-A989-9F9261CE4E8CQ46493856-62B147AE-A673-4E3A-8777-04DFF94A597AQ47099578-0B5924C5-921D-4830-9EEA-10475C3E9A30
P2860
Systematic review on urine albumin testing for early detection of diabetic complications.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Systematic review on urine albumin testing for early detection of diabetic complications.
@ast
Systematic review on urine albumin testing for early detection of diabetic complications.
@en
type
label
Systematic review on urine albumin testing for early detection of diabetic complications.
@ast
Systematic review on urine albumin testing for early detection of diabetic complications.
@en
prefLabel
Systematic review on urine albumin testing for early detection of diabetic complications.
@ast
Systematic review on urine albumin testing for early detection of diabetic complications.
@en
P2093
P356
P1476
Systematic review on urine albumin testing for early detection of diabetic complications.
@en
P2093
Mattock MB
P304
iii-vi, xiii-163
P356
10.3310/HTA9300
P577
2005-08-01T00:00:00Z